The therapeutic effect and MR molecular imaging of FA-PEG-FePt/DDP nanoliposomes in AMF on ovarian cancer
DOI: https://doi.org/10.2147/ijn.s453601
IF: 7.033
2024-06-06
International Journal of Nanomedicine
Abstract:Xuefeng Bian, 1, &ast Ting Guo, 2, &ast Guojie Chen, 2, &ast Dengyun Nie, 2 Miao Yue, 2 Yinxing Zhu, 2 Mei Lin 3 1 Imaging Department, The Affiliated Taizhou People's Hospital of Nanjing Medical University, Taizhou School of Clinical Medicine, Nanjing Medical University, Taizhou, People's Republic of China; 2 Institute of Clinical Medicine, The Affiliated Taizhou People's Hospital of Nanjing Medical University, Taizhou School of Clinical Medicine, Nanjing Medical University, Taizhou, People's Republic of China; 3 Clinical Medical Laboratory, The Affiliated Taizhou People's Hospital of Nanjing Medical University, Taizhou School of Clinical Medicine, Nanjing Medical University, Taizhou, People's Republic of China &astThese authors contributed equally to this work Correspondence: Mei Lin; Yinxing Zhu, Email ; Purpose: This study aimed to construct targeting drug-loading nanocomposites (FA-FePt/DDP nanoliposomes) to explore their potential in ovarian cancer therapy and molecular magnetic resonance imaging (MMRI). Methods: FA-FePt-NPs were prepared by coupling folate (FA) with polyethylene-glycol (PEG)-coated ferroplatinum nanoparticles and characterized. Then cisplatin (DDP) was encapsulated in FA-FePt-NPs to synthesize FA-PEG-FePt/DDP nanoliposomes by thin film-ultrasonic method and high-speed stirring, of which MMRI potential, magnetothermal effect, and the other involved performance were analyzed. The therapeutic effect of FA-FePt/DDP nanoliposomes combined with magnetic fluid hyperthermia (MFH) on ovarian cancer in vitro and in vivo was evaluated. The expression levels of Bax and epithelial–mesenchymal transition related proteins were detected. The biosafety was also preliminarily observed. Results: The average diameter of FA-FePt-NPs was about 30 nm, FA-FePt/DDP nanoliposomes were about 70 nm in hydrated particle size, with drug slow-release and good cell-specific targeted uptake. In an alternating magnetic field (AMF), FA-FePt/DDP nanoliposomes could rapidly reach the ideal tumor hyperthermia temperature (42~44 °C). MRI scan showed that FA-FePt-NPs and FA-FePt/DDP nanoliposomes both could suppress the T2 signal, indicating a good potential for MMRI. The in vitro and in vivo experiments showed that FA-FePt/DDP-NPs in AMF could effectively inhibit the growth of ovarian cancer by inhibiting cancer cell proliferation, invasion, and migration, and inducing cancer cell apoptosis, much better than that of the other individual therapies; molecularly, E-cadherin and Bax proteins in ovarian cancer cells and tissues were significantly increased, while N-cadherin, Vimentin, and Bcl-2 proteins were inhibited, effectively inhibiting the malignant progression of ovarian cancer. In addition, no significant pathological injury and dysfunction was observed in major visceras. Conclusion: We successfully synthesized FA-FePt/DDP nanoliposomes and confirmed their good thermochemotherapeutic effect in AMF and MMRI potential on ovarian cancer, with no obvious side effects, providing a favorable strategy of integrated targeting therapy and diagnosis for ovarian cancer. Keywords: iron–platinum magnetic nanoparticles, ovarian cancer, DDP, molecular magnetic resonance imaging, folate As one of the common tumors in the female reproductive system, ovarian cancer lists first among gynecological tumors in mortality. 1 Although considerable progress has been made, the diagnosis and therapy of ovarian cancer are not satisfactory. Up to the present, the pathological examination remains the gold standard for the diagnosis of ovarian cancer; however, the process is invasive and it is difficult to detect the tumor tissue in non-surgery. 2 Surgery combined with chemotherapy is considered the routine method for the treatment of ovarian cancer, 3 but most patients are at advanced stage and lose the best chance of surgery because of ovarian cancer concealment. Concurrently, most of the current medications are administered intravenously and have non-selectivity of cancer tissue. As a result, it is difficult for the anti-tumor medicine to maintain high concentration in the lesion location, leading to poor efficacy and severe side effects. 4,5 Therefore, it is in great demand to seek a non-invasive, safe, sensitive, and accurate diagnosis method and effective therapy with less adverse effects for ovarian cancer. Magnetic resonance imaging (MRI), an extensively applied non-invasive medical diagnostic technology at present, has unique advantages in the diagnosis of various tumors, such as liver cancer, cervical cancer, ovarian cancer, glioma, and other tumors, due to its hi -Abstract Truncated-
pharmacology & pharmacy,nanoscience & nanotechnology